Cited by 38Hepatitis C virus researchHIV, Drug Use, Sexual RiskHIV/AIDS Research and Interventions

Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center.

Open access
Garg, S., Taylor, L. E., Grasso, C., Mayer, K. H.·2013·Clinical Infectious Diseases

Abstract

BACKGROUND: Sexually transmitted hepatitis C virus (HCV) infection is an emerging epidemic among human immunodeficiency virus (HIV)-infected men who have sex with men (MSM). HCV may be underrecognized in this population, historically thought to be at low risk. METHODS: We determined the prevalence and incidence of HCV among HIV-infected men at Fenway Health between 1997 and 2009. We describe characteristics associated with HCV. RESULTS: Of 1171 HIV-infected men, of whom 96% identify as MSM, 1068 (91%) were screened for HCV and 64 (6%) had a positive HCV antibody (Ab) result at initial screening. Among the 995 men whose initial HCV Ab result was negative, 62% received no further HCV Ab testing. Among the 377 men who had ≥1 additional HCV Ab test, 23 (6%) seroconverted over 1408 person-years, for an annualized incidence of 1.63 per 100 person-years (95% confidence interval, .97-2.30). Among the 87 HIV-infected MSM diagnosed with prevalent or incident HCV, 33% reported history of injection drug use, 46% noninjection drug use (NIDU), and 70% sexually transmitted infections (STIs). Sixty-four (74%) of HCV-infected MSM developed chronic HCV; 22 (34%) initiated HCV treatment and 13 (59%) of treated persons achieved a sustained virologic response (SVR). CONCLUSIONS: Prevalent and incident HCV, primarily acquired through nonparenteral means, was common in this HIV-infected population despite engagement in care. STIs and NIDU were common among HIV/HCV-coinfected MSM. SVR rates were high among those who underwent HCV treatment. All sexually active and/or substance-using HIV-infected MSM should receive routine and repeated HCV screening to allow for early diagnosis and treatment of HCV.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cit054

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Sexual transmission of HCV can occur and is most common among MSM with HIV infection.

    “Sexual transmission of HCV can occur and is most common among MSM with HIV infection (234–237).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [236]

    The Abstract describes sexually transmitted HCV as an emerging epidemic among MSM with HIV, and the Discussion says high-risk sexual behaviors appear to play a role in transmission. The paper does not compare sexual HCV transmission across populations, so it does not establish that it is most common among MSM with HIV. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • Increasing incidence of acute HCV infection among MSM with HIV infection has been reported in multiple U.S. and European cities.

    “Increasing incidence of acute HCV infection among MSM with HIV infection has been reported in multiple U.S. (96,236,239,1339) and European cities (237,1340–1342).”

    From Sexually Transmitted Infections Treatment Guidelines, 2021 (2021) · cites this paper as [236]

    The Results report that diagnosed incident HCV cases increased over time at the Boston clinic. But the paper does not establish an increasing incidence rate across multiple U.S. cities, and the Discussion says it could not determine whether incident cases were acute infections. It separately reports increasing incidence in European cohorts; the cited paper supports a narrower U.S. finding than the claim attributes to it. (LLM, conf=0.88)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Fierer D, Khudyakov Y, Hare B, et al. Molecular epidemiology of inci- dent HCV infection in HIV-infected MSM in the US versus infections in Europe and Australia. In: 18th Conference on Retroviruses and Opportu- nistic Infections, Boston, MA, 27 February-2 March 2011. Session 34.
  2. Centers for Disease Control and Prevention. Sexual transmission of hepati- tis C virus among HIV-infected men who have sex with men-New York City, 2005-2010. MMWR Morb Mortal Wkly Rep 2011; 60:945-50.

Cited by

Sorted by citations

Authors
Garg, S., Taylor, L. E., Grasso, C., & Mayer, K. H.
Affiliations
  • Tufts Medical Center (US)
  • Brown University (US)
  • Fenway Health (US)
  • Beth Israel Deaconess Medical Center (US)
Corresponding author
Garg, S.
Venue
Clinical Infectious Diseases
Published
2013-02-05
Volume
56
Issue
10
Pages
1480-1487
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2102616164
Cited by
38
References
44
Citations by year
2024: 1 · 2021: 2 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 11 · 2015: 4 · 2014: 4 · 2013: 5
FWCI
4.98
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health (5t32ai007438-20)
  • National Institute on Drug Abuse (K23DA020383)
  • National Institute of Allergy and Infectious Diseases (T32-AI007438, 5T32AI007438-17, P30AI042853)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatitis C virus research
  • Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
hepatitis C virus, HIV/HCV coinfection, men who have sex with men, sexually transmitted infections, HCV screening, HCV seroconversion, chronic hepatitis C, sustained virological response, hepatitis C treatment, primary care
MeSH terms
Adolescent, Adult, Aged, Boston, Community Health Centers, Hepatitis C, Humans, Male, Mass Screening, Middle Aged, Retrospective Studies, HIV Infections, Incidence, Prevalence, Homosexuality, Male, Statistics, Nonparametric

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review